Technology work is a mainstay at Horn & Co, with the boutique firm specialising in all aspects of hi-tech and life sciences law. Among its core practices, it houses standalone offerings in venture capital, M&A, securities, IP transactions and regulatory work, where it acts for start-ups through to prominent multinational technology companies. Name partner Yuval Horn is a 30-year veteran in technology transactions, while Keren Kanir specialises in corporate finance and commercial transactions relating to IP.
Testimonials
Collated independently by Legal 500 research team.
‘A very professional, dedicated, and effective team.’
Key clients
- Biosight
- Panaxia Pharmaceutical Industries
Work highlights
- Advised INX Digital Company on a series of agreements with Republic for a multi-step financial and commercial collaboration.
- Acted for the shareholders of Immunorizon in the company’s acquisition, through a share purchase agreement, by Purple Biotech.